Skip to main content

Table 5 Information related to dialysis therapy for each patient (control group)

From: Clinical advantages of a newly launched anti-thrombotic PMMA membrane for the nutritional status and dialysis-related symptoms in older chronic dialysis patients: a multicenter pilot study

Pt, no.

Dialysis membrane

(PS/PES/PEPA)

Surface area

(m2)

Classification of dialyzera

(I·II/III/IV/V)

Blood flow rate

(mL/min)

Dialysate flow rate

(mL/min)

Dialysate

(Acetate:+/−)

Dialysis time

(h)

1

PS

2.1

Type V

230

500

+

4.0

2

PS

2.1

Type V

230

500

+

4.0

3

PS

2.1

Type V

200

500

+

4.0

4

PS

2.1

Type V

240

500

+

4.0

5

PS

2.1

Type V

250

500

+

4.0

6

PS

1.4

Type IV

150

500

+

3.0

7

PS

1.4

Type IV

150

500

+

4.0

8

PES

1.5

Type V

230

500

+

4.0

9

PS

1.8

Type V

230

500

+

4.0

10

PES

1.5

Type V

230

500

+

4.0

11

PEPA

1.8

Type V

250

500

+

4.0

12

PES

2.1

Type IV

250

500

+

4.0

13

PEPA

1.5

Type IV

250

500

+

4.5

14

PEPA

1.5

Type IV

230

500

+

4.0

15

PS

1.8

Type IV

250

500

+

4.0

16

PS

2.1

Type V

200

500

+

5.0

17

PES

1.8

Type IV

230

500

+

3.5

18

PS

1.5

Type V

250

500

+

3.5

19

PS

1.5

Type IV

240

500

+

4.0

20

PS

1.8

Type IV

200

500

+

4.5

21

PS

1.5

Type IV

220

500

+

4.0

22

PS

1.5

Type III

200

500

−

4

23

PS

1.5

Type III

200

500

+

4

24

PS

1.5

Type III

200

500

−

4

25

PS

1.5

Type III

200

500

+

4

26

PS

2.1

Type III

200

500

+

4

  1. aClassification of dialyzers in the Japanese reimbursement system